300 related articles for article (PubMed ID: 18083018)
1. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association.
McMahon M; Hahn BH
Curr Opin Immunol; 2007 Dec; 19(6):633-9. PubMed ID: 18083018
[TBL] [Abstract][Full Text] [Related]
2. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
Bassi N; Ghirardello A; Iaccarino L; Zampieri S; Rampudda ME; Atzeni F; Sarzi-Puttini P; Shoenfeld Y; Doria A
Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis in autoimmune diseases.
Matsuura E; Kobayashi K; Lopez LR
Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
[TBL] [Abstract][Full Text] [Related]
4. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis.
George J; Harats D; Gilburd B; Levy Y; Langevitz P; Shoenfeld Y
Lupus; 1999; 8(3):220-6. PubMed ID: 10342715
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematosus, atherosclerosis, and autoantibodies.
Zampieri S; Iaccarino L; Ghirardello A; Tarricone E; Arienti S; Sarzi-Puttini P; Gambari P; Doria A
Ann N Y Acad Sci; 2005 Jun; 1051():351-61. PubMed ID: 16126977
[TBL] [Abstract][Full Text] [Related]
7. High-density lipoprotein functionality in systemic lupus erythematosus.
Ganjali S; Shirmohammadi L; Read MI; Sahebkar A
Semin Arthritis Rheum; 2020 Aug; 50(4):769-775. PubMed ID: 32531506
[TBL] [Abstract][Full Text] [Related]
8. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
[TBL] [Abstract][Full Text] [Related]
9. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
11. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
12. Traditional and nontraditional risk factors for atherosclerosis in patients with systemic lupus erythematosus.
Pompilian V; Badea C; Dragomanu I; Bălăşescu E; Tănăsescu C
Rom J Intern Med; 2008; 46(3):195-8. PubMed ID: 19366077
[TBL] [Abstract][Full Text] [Related]
13. SLE, atherosclerosis and cardiovascular disease.
Frostegård J
J Intern Med; 2005 Jun; 257(6):485-95. PubMed ID: 15910552
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies.
Hahn BH; McMahon M
Lupus; 2008 May; 17(5):368-70. PubMed ID: 18490409
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity, oxidized LDL and cardiovascular disease.
Frostegård J
Autoimmun Rev; 2002 Aug; 1(4):233-7. PubMed ID: 12849001
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis in systemic lupus erythematosus.
Sherer Y; Zinger H; Shoenfeld Y
Autoimmunity; 2010 Feb; 43(1):98-102. PubMed ID: 20014976
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL.
Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G
Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894
[TBL] [Abstract][Full Text] [Related]
18. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
Kobayashi K; Lopez LR; Matsuura E
Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
[TBL] [Abstract][Full Text] [Related]
19. Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease.
Reiss AB; Anwar K; Merrill JT; Chan ES; Awadallah NW; Cronstein BN; Michael Belmont H; Belilos E; Rosenblum G; Belostocki K; Bonetti L; Hasneen K; Carsons SE
Rheumatol Int; 2010 Mar; 30(5):591-8. PubMed ID: 19547978
[TBL] [Abstract][Full Text] [Related]
20. Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases.
Wang Y; Yu H; He J
Discov Med; 2020; 30(159):49-56. PubMed ID: 33357362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
